Calarco, Cali A Lobo, Mary Kay
Published in
International review of neurobiology
Mood disorders, including major depressive disorder (MDD), are the most prevalent psychiatric illnesses, and pose an incredible burden to society, both in terms of disability and in terms of costs associated with medical care and lost work time. MDD has extremely high rates of comorbidity with substance use disorders (SUD) as many of the same neuro...
Cucinello-Ragland, Jessica A Edwards, Scott
Published in
International review of neurobiology
Alcohol is an effective and widely utilized analgesic. However, the chronic use of alcohol can actually facilitate nociceptive sensitivity over time, a condition known as hyperalgesia. Excessive and uncontrollable alcohol drinking is also a hallmark feature of alcohol use disorder (AUD). Both AUD and chronic pain are typically accompanied by negati...
McGinn, M Adrienne Pantazis, Caroline B Tunstall, Brendan J Marchette, Renata C N Carlson, Erika R Said, Nadia Koob, George F Vendruscolo, Leandro F
Published in
International review of neurobiology
Addiction is a chronic disorder that consists of a three-stage cycle of binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation. These stages involve, respectively, neuroadaptations in brain circuits involved in incentive salience and habit formation, stress surfeit and reward deficit, and executive function. Much research on...
Jacotte-Simancas, Alejandra Fucich, Elizabeth A Stielper, Zachary F Molina, Patricia E
Published in
International review of neurobiology
Traumatic brain injury (TBI), most often classified as concussion, is caused by biomechanical forces to the brain resulting in short- or long-term impairment in brain function. TBI resulting from military combat, sports, violence, falls, and vehicular accidents is a major cause of long-term physical, cognitive, and psychiatric dysfunction. Psychiat...
Carlson, Hannah N Weiner, Jeff L
Published in
International review of neurobiology
Alcohol use disorder (AUD) and (PTSD) frequently co-occur and individuals suffering from this dual diagnosis often exhibit increased symptom severity and poorer treatment outcomes than those with only one of these diseases. Although there have been significant advances in our understanding of the neurobiological mechanisms underlying each of these ...
Massaly, Nicolas Markovic, Tamara Creed, Meaghan Al-Hasani, Ream Cahill, Catherine M Moron, Jose A
Published in
International review of neurobiology
Across centuries and civilizations opioids have been used to relieve pain. In our modern societies, opioid-based analgesics remain one of the most efficient treatments for acute pain. However, the long-term use of opioids can lead to the development of analgesic tolerance, opioid-induced hyperalgesia, opioid use disorders, and overdose, which can u...
Gilpin, Nicholas W Calipari, Erin S
Published in
International review of neurobiology
Kondev, Veronika Winters, Nathan Patel, Sachin
Published in
International review of neurobiology
Cannabis use is increasing among some demographics in the United States and is tightly linked to anxiety, trauma, and stress reactivity at the epidemiological and biological level. Stress-coping motives are highly cited reasons for cannabis use. However, with increased cannabis use comes the increased susceptibility for cannabis use disorder (CUD)....
Melugin, Patrick R Nolan, Suzanne O Siciliano, Cody A
Published in
International review of neurobiology
Cognitive deficits are highly comorbid with substance use disorders. Deficits span multiple cognitive domains, are associated with disease severity across substance classes, and persist long after cessation of substance use. Furthermore, recovery of cognitive function during protracted abstinence is highly predictive of treatment adherence, relapse...
Lucerne, Kelsey E Kiraly, Drew D
Published in
International review of neurobiology
Substance use disorders (SUDs) are debilitating neuropsychiatric conditions that exact enormous costs in terms of loss of life and individual suffering. While much progress has been made defining the neurocircuitry and intracellular signaling cascades that contribute to SUDs, these studies have yielded limited effective treatment options. This has ...